General Rheumatology

Is COVID-19-Associated Arthritis a New Disease Entity?

Practice Management

Medicine vs Food: The Patient Care Dilemma of "Financial Toxicity"

General Rheumatology

Welcome to the New and Improved Rheumatology Advisor
More News

Latest News

Features

 More features
Is COVID-19-Associated Arthritis a New Disease Entity?
 By Peter J. Stein, PhD, DC

Based on existing literature, the potential mechanism, clinical characteristics, and treatment of COVID-19-associated arthritis is discussed.

Medicine vs Food: The Patient Care Dilemma of “Financial Toxicity”
 By Jody A. Charnow
Welcome to the New and Improved Rheumatology Advisor
 By Meghna Rao
EULAR Releases Points-to-Consider to Improve Work Participation Among Patients With Rheumatic Diseases
 By Inga Back, MPH

Features

Is COVID-19-Associated Arthritis a New Disease Entity?
 By Peter J. Stein, PhD, DC
Medicine vs Food: The Patient Care Dilemma of “Financial Toxicity”
 By Jody A. Charnow
Welcome to the New and Improved Rheumatology Advisor
 By Meghna Rao
EULAR Releases Points-to-Consider to Improve Work Participation Among Patients With Rheumatic Diseases
 By Inga Back, MPH

Conference Coverage

MORE MEETINGS

Featured Conference

American College of Rheumatology

Clinical Tools

Powered by

Powered by   
Drug Look-up
Select a category
Drug Comparison Charts
Select a category
Calculators
Select a category
MORE CLINICAL TOOLS

More From

EXPLORE OUR NETWORK

Pirfenidone Promising for RA-Linked Interstitial Lung Disease

Guselkumab and Risankizumab Have Highest Drug Persistence in Plaque Psoriasis

Meta-Analysis Shows Safety of COVID-19 Vaccination During Pregnancy

Acupuncture Reduces Anxiety Levels in Patients with Parkinson Disease

Methotrexate Added to Pegloticase for Gout Safe for Kidneys

CME/CE

MORE COURSES

Topics

More Topics